TY - JOUR AU - Lee, D. M. AU - Weinblatt, M. E. PY - 2001 DA - 2001// TI - Rheumatoid arthritis JO - Lancet VL - 358 UR - https://doi.org/10.1016/S0140-6736(01)06075-5 DO - 10.1016/S0140-6736(01)06075-5 ID - Lee2001 ER - TY - JOUR AU - Brennan, F. M. AU - Maini, R. N. AU - Feldmann, M. PY - 1992 DA - 1992// TI - TNF α-a pivotal role in rheumatoid arthritis? JO - Br J Rheumatol VL - 31 UR - https://doi.org/10.1093/rheumatology/31.5.293 DO - 10.1093/rheumatology/31.5.293 ID - Brennan1992 ER - TY - JOUR PY - 2002 DA - 2002// TI - Guidelines for the management of rheumatoid arthritis: 2002 update JO - Arthritis Rheum VL - 46 UR - https://doi.org/10.1002/art.10148 DO - 10.1002/art.10148 ID - ref3 ER - TY - JOUR AU - Furst, D. E. AU - Breedveld, F. C. AU - Kalden, J. R. AU - Smolen, J. S. AU - Burmester, G. R. AU - Dougados, M. AU - Emery, P. AU - Gibofsky, A. AU - Kavanaugh, A. F. AU - Keystone, E. C. AU - Klareskog, L. AU - Russell, A. S. AU - van de Putte, L. B. AU - Weisman, M. H. PY - 2003 DA - 2003// TI - Updated consensus statement on biological agents for the treatment of rheumatoid arthritis and other immune mediated inflammatory diseases (May 2003) JO - Ann Rheum Dis VL - 62 ID - Furst2003 ER - TY - JOUR AU - Hochberg, M. C. AU - Lebwohl, M. G. AU - Plevy, S. E. AU - Hobbs, K. F. AU - Yocum, D. E. PY - 2005 DA - 2005// TI - The benefit/risk profile of TNF-blocking agents: findings of a consensus panel JO - Semin Arthritis Rheum VL - 34 UR - https://doi.org/10.1016/j.semarthrit.2004.11.006 DO - 10.1016/j.semarthrit.2004.11.006 ID - Hochberg2005 ER - TY - JOUR AU - Olsen, N. J. AU - Stein, C. M. PY - 2004 DA - 2004// TI - New drugs for rheumatoid arthritis JO - N Engl J Med VL - 350 UR - https://doi.org/10.1056/NEJMra032906 DO - 10.1056/NEJMra032906 ID - Olsen2004 ER - TY - JOUR AU - Bongartz, T. AU - Sutton, A. J. AU - Sweeting, M. J. AU - buchan, I. AU - Matteson, E. L. AU - Montori, V. PY - 2006 DA - 2006// TI - Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials JO - JAMA VL - 295 UR - https://doi.org/10.1001/jama.295.19.2275 DO - 10.1001/jama.295.19.2275 ID - Bongartz2006 ER - TY - JOUR AU - Hochberg, M. C. AU - Tracy, J. K. AU - Hawkins-Holt, M. AU - Flores, R. H. PY - 2003 DA - 2003// TI - Comparison of the efficacy of the tumour necrosis factor α blocking agents adalimumab, etanercept, and infliximab when added to methotrexate in patients with active rheumatoid arthritis JO - Ann Rheum Dis VL - 62 ID - Hochberg2003 ER - TY - JOUR AU - Arnett, F. C. AU - Edworthy, S. M. AU - Bloch, D. A. AU - McShane, D. J. AU - Fries, J. F. AU - Cooper, N. S. PY - 1988 DA - 1988// TI - The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis JO - Arthritis Rheum VL - 31 UR - https://doi.org/10.1002/art.1780310302 DO - 10.1002/art.1780310302 ID - Arnett1988 ER - TY - JOUR AU - Felson, D. T. AU - Anderson, J. J. AU - Boers, M. AU - Bonbardier, C. AU - Furst, D. AU - Goldsmith, C. AU - Katz, L. M. AU - Lightfoot, R. AU - Paulus, H. AU - Strand, V. PY - 1995 DA - 1995// TI - American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis JO - Arthritis Rheum VL - 38 UR - https://doi.org/10.1002/art.1780380602 DO - 10.1002/art.1780380602 ID - Felson1995 ER - TY - JOUR AU - Jadad, A. r. AU - Moore, R. A. AU - Carroll, D. AU - Jenkinson, C. AU - Reynols, D. J. AU - Gavaghan, D. J. PY - 1996 DA - 1996// TI - Assessing the quality of reports of randomized clinical trils: is binding necessary? JO - Control Clin Trials VL - 17 UR - https://doi.org/10.1016/0197-2456(95)00134-4 DO - 10.1016/0197-2456(95)00134-4 ID - Jadad1996 ER - TY - JOUR AU - Higgins, J. P. T. AU - Thompson, S. G. AU - Dees Deeks, J. J. AU - Altman, D. G. PY - 2003 DA - 2003// TI - Measuring inconsistency in meta-analysis JO - BMJ VL - 327 UR - https://doi.org/10.1136/bmj.327.7414.557 DO - 10.1136/bmj.327.7414.557 ID - Higgins2003 ER - TY - JOUR AU - Osiri, M. AU - Suarez-Almanzor, M. E. AU - Wells, G. A. AU - Robinson, V. AU - Tugwell, P. PY - 2003 DA - 2003// TI - Number needed to treat (NNT): implication in rheumatology clinical practice JO - Ann Rheum Dis VL - 62 UR - https://doi.org/10.1136/ard.62.4.316 DO - 10.1136/ard.62.4.316 ID - Osiri2003 ER - TY - CHAP AU - Sackett, D. L. AU - Haynes, R. B. PY - 1997 DA - 1997// TI - Summarising the effects of therapy: a new table and some more terms (EBM Notebook) BT - Evidence-Based Medicine ID - Sackett1997 ER - TY - JOUR AU - Laupacis, A. AU - Sackett, D. L. AU - Roberts, R. S. PY - 1988 DA - 1988// TI - An assessment of clinically useful measures of the consequencs of treatment JO - N Engl J Med VL - 318 UR - https://doi.org/10.1056/NEJM198806303182605 DO - 10.1056/NEJM198806303182605 ID - Laupacis1988 ER - TY - JOUR AU - Sterne, J. A. C. AU - Egger, M. PY - 2001 DA - 2001// TI - Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis JO - J Clin Epidemiol VL - 54 UR - https://doi.org/10.1016/S0895-4356(01)00377-8 DO - 10.1016/S0895-4356(01)00377-8 ID - Sterne2001 ER - TY - JOUR AU - Egger, M. AU - Smith, G. D. AU - Scheider, M. AU - Minder, C. PY - 1997 DA - 1997// TI - Bias in meta-analysis detected by a simple, graphical test JO - BMJ VL - 315 UR - https://doi.org/10.1136/bmj.315.7109.629 DO - 10.1136/bmj.315.7109.629 ID - Egger1997 ER - TY - JOUR AU - Beg, C. B. AU - Mazumdar, M. PY - 1994 DA - 1994// TI - Operating characteristic of a rank correlation test for publication bias JO - Biometrics VL - 50 UR - https://doi.org/10.2307/2533446 DO - 10.2307/2533446 ID - Beg1994 ER - TY - JOUR AU - Lipsky, P. E. AU - van der Heijde, D. M. AU - St. Clair, E. W. AU - Furst, D. E. AU - Breedveld, F. C. AU - Kolden, J. R. AU - Smolen, J. S. AU - Weisman, M. AU - Emery, P. AU - Feldmann, M. AU - Harriman, G. R. AU - Maini, R. N. PY - 2000 DA - 2000// TI - Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group JO - N Engl J Med VL - 343 UR - https://doi.org/10.1056/NEJM200011303432202 DO - 10.1056/NEJM200011303432202 ID - Lipsky2000 ER - TY - JOUR AU - St. Clair, E. W. AU - van der Heijde, D. M. AU - Smolen, J. AU - Maini, R. N. AU - Bathon, J. M. AU - Emery, P. AU - Keystone, E. AU - Schiff, M. AU - Kalden, J. R. AU - Wang, B. AU - Dewoody, K. AU - Weiss, R. AU - Baker, D. PY - 2004 DA - 2004// TI - Combination of infliximab and methotrexate therapy for early rheumatoid arthritis. A randomized, controlled trial JO - Arthritis Rheum VL - 50 UR - https://doi.org/10.1002/art.20568 DO - 10.1002/art.20568 ID - St. Clair2004 ER - TY - JOUR AU - Maini, R. N. AU - St Clair, E. W. AU - Breedveld, F. AU - Furst, D. AU - Kalden, J. R. AU - Weisman, M. AU - Smolen, J. AU - Harriman, G. AU - Feldmann, M. AU - Lipsky, P. PY - 1999 DA - 1999// TI - Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial JO - Lancet VL - 354 UR - https://doi.org/10.1016/S0140-6736(99)05246-0 DO - 10.1016/S0140-6736(99)05246-0 ID - Maini1999 ER - TY - JOUR AU - Quinn, M. A. AU - Conaghan, P. G. AU - O'Connor, P. J. AU - Karim, Z. AU - Greenstein, A. AU - Brown, A. AU - Brown, C. AU - Fraser, A. AU - Jarret, S. AU - Emery, P. PY - 2005 DA - 2005// TI - Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: Results from a twelve-month randomized, double-blind, placebo-controlled trial JO - Arthritis Rheum VL - 52 UR - https://doi.org/10.1002/art.20712 DO - 10.1002/art.20712 ID - Quinn2005 ER - TY - JOUR AU - Westhovens, R. AU - Yocum, D. AU - Han, J. AU - Berman, A. AU - Strusberg, I. AU - Geusens, P. AU - Rahman, M. U. PY - 2006 DA - 2006// TI - The safety of infliximab, combined with background treatments, among patients with rheumatoid arthritis and various comorbidities. A large, randomized, placebo-controlled trial JO - Arthritis Rheum VL - 54 UR - https://doi.org/10.1002/art.21734 DO - 10.1002/art.21734 ID - Westhovens2006 ER - TY - JOUR AU - Moreland, L. W. AU - Schiff, M. H. AU - Baumgartner, S. W. AU - Tindall, E. A. AU - Fleischmann, R. M. AU - Bulpitt, K. J. AU - Bulpitt, K. J. AU - Martin, R. AU - Weinblatt, M. AU - Taborn, J. AU - Weaver, A. AU - Burge, D. J. AU - Schiff, M. h. PY - 1999 DA - 1999// TI - Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial JO - Ann Intern Med VL - 130 UR - https://doi.org/10.7326/0003-4819-130-6-199903160-00004 DO - 10.7326/0003-4819-130-6-199903160-00004 ID - Moreland1999 ER - TY - JOUR AU - Weinblatt, M. E. AU - Kremer, J. M. AU - Bankhurst, A. D. AU - Bulpitt, K. J. AU - Fleischmann, R. M. AU - Fox, R. I. AU - Jackson, C. G. AU - Lange, M. AU - Burge, D. J. PY - 1999 DA - 1999// TI - A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate JO - N Engl J Med VL - 340 UR - https://doi.org/10.1056/NEJM199901283400401 DO - 10.1056/NEJM199901283400401 ID - Weinblatt1999 ER - TY - JOUR AU - Bathon, J. M. AU - Martin, R. W. AU - Fleischmann, R. M. AU - Tesser, J. R. AU - Schiff, M. H. AU - Keystone, E. C. AU - Genovese, M. C. AU - Wasko, M. C. AU - Moreland, L. W. AU - Weaver, A. L. AU - Markenson, J. AU - Fink, B. K. PY - 2000 DA - 2000// TI - A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis JO - N Engl J Med VL - 343 UR - https://doi.org/10.1056/NEJM200011303432201 DO - 10.1056/NEJM200011303432201 ID - Bathon2000 ER - TY - JOUR AU - Klareskog, L. AU - van der Heijde, D. AU - de Jager, J. P. AU - Gough, A. AU - Kalden, J. AU - Malise, M. AU - Martin Mola, E. AU - Pavelka, K. AU - Sany, J. AU - Settas, L. AU - Wajdula, J. AU - Pedersen, R. AU - Fateneland, S. AU - Sanda, M. PY - 2004 DA - 2004// TI - Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial JO - Lancet VL - 363 UR - https://doi.org/10.1016/S0140-6736(04)15640-7 DO - 10.1016/S0140-6736(04)15640-7 ID - Klareskog2004 ER - TY - JOUR AU - van der Heijde, D. AU - Klareskog, L. AU - Rodríguez-Valverde, V. AU - Codreanu, C. AU - Bolosiu, H. AU - Melo-Gomes, J. AU - Tornero-Molina, J. AU - Wajdula, J. AU - Pedersen, R. AU - Fatenejad, S. PY - 2006 DA - 2006// TI - Comparison of etaercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis. Two-year clinical and radiographic results from the TEMPO study, a double-blind, randomized trial JO - Arthritis Rheum VL - 54 UR - https://doi.org/10.1002/art.21655 DO - 10.1002/art.21655 ID - van der Heijde2006 ER - TY - JOUR AU - Weinblatt, M. E. AU - Keystone, E. C. AU - Furst, D. E. AU - Moreland, L. W. AU - Weisman, M. H. AU - Birbara, C. A. AU - Teoh, L. A. AU - Fischkoff, S. A. AU - Chartash, E. K. PY - 2003 DA - 2003// TI - Adalimumab, a fully human anti-tumor necrosis factor α monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial JO - Arthritis Rheum VL - 48 UR - https://doi.org/10.1002/art.10697 DO - 10.1002/art.10697 ID - Weinblatt2003 ER - TY - JOUR AU - van de Putte, L. B. A. AU - Atkins, C. AU - Malaise, M. AU - Sany, J. AU - Russell, A. S. AU - van Riel, P. L. C. M. AU - Settas, L. AU - Bijlsma, J. W. AU - Todesco, S. AU - Dougados, M. AU - Nash, P. AU - Emery, P. AU - Walter, M. AU - Kaul, M. AU - Fischkoff, S. AU - Kupper, H. PY - 2004 DA - 2004// TI - Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed JO - Ann Rheum Dis VL - 63 UR - https://doi.org/10.1136/ard.2003.013052 DO - 10.1136/ard.2003.013052 ID - van de Putte2004 ER - TY - JOUR AU - Furst, D. E. AU - Schiff, M. H. AU - Fleischmann, R. M. AU - Strand, V. AU - Birbara, C. A. AU - Compagnone, D. AU - Fischkoff, S. A. AU - Chartash, E. K. PY - 2003 DA - 2003// TI - Adalimumab, a fully human anti-tumor necrosis factor-α monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis) JO - J Rheumatol VL - 30 ID - Furst2003 ER - TY - JOUR AU - Keystone, E. C. AU - Kavanaugh AU - Sharp, J. T. AU - Tannenbaum, H. AU - Hua, Y. AU - Teoh, L. S. AU - Fischkoff, S. A. AU - Chartash, E. K. PY - 2004 DA - 2004// TI - Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid artritis receiving concomitant methotrexate therapy. A randomized, placebo-controlled, 52-week trial JO - Arthritis Rheum VL - 50 UR - https://doi.org/10.1002/art.20217 DO - 10.1002/art.20217 ID - Keystone2004 ER - TY - JOUR AU - Breedveld, F. C. AU - Weisman, M. H. AU - Kavanaugh, A. F. AU - Cohen, S. B. AU - Pavelka, K. AU - van Vollenhoven, R. AU - Sharp, J. AU - Perez, J. L. AU - Spencer-Green, G. T. PY - 2006 DA - 2006// TI - The PREMIER study. A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment JO - Arthritis Rheum VL - 54 UR - https://doi.org/10.1002/art.21519 DO - 10.1002/art.21519 ID - Breedveld2006 ER - TY - JOUR AU - Temekonidis, T. I. AU - Georgiadis, A. N. AU - Alamanos, Y. AU - Bougias, D. V. AU - Voulgari, P. V. AU - Dorsos, A. A. PY - 2002 DA - 2002// TI - Infliximab treatment in combination with cyclosporin A in patients with severe refractory rheumatoid arthritis JO - Ann Rheum Dis VL - 61 UR - https://doi.org/10.1136/ard.61.9.822 DO - 10.1136/ard.61.9.822 ID - Temekonidis2002 ER - TY - JOUR AU - Genovese, M. C. AU - Bathon, J. M. AU - Martin, R. W. AU - Fleischmann, R. M. AU - Tesser, J. R. AU - Schiff, M. H. AU - Keystone, E. C. AU - Wasko, M. C. AU - Moreland, L. W. AU - Weaver, A. L. AU - Markenson, J. AU - Cannon, G. W. AU - Spencer-Green, G. AU - Finck, B. K. PY - 2002 DA - 2002// TI - Etanercept versus methotrexate in patients with early rheumatoid arthritis: two-year radiographic and clinical outcomes JO - Arthritis Rheum VL - 46 UR - https://doi.org/10.1002/art.10308 DO - 10.1002/art.10308 ID - Genovese2002 ER - TY - JOUR AU - Barrera, P. AU - van der Maas, A. AU - van Ede, A. E. AU - Kiemeney, B. A. AU - Laan, R. F. AU - van de Putte AU - van Riel, P. L. PY - 2002 DA - 2002// TI - Drug survival, efficacy and toxicity of monotherapy with a fully human anti-tumour necrosis factor-alpha antibody compared with methotrexate in long-standing rheumatoid arthritis JO - Rheumatology (Oxford) VL - 41 UR - https://doi.org/10.1093/rheumatology/41.4.430 DO - 10.1093/rheumatology/41.4.430 ID - Barrera2002 ER - TY - JOUR AU - Moreland, L. W. AU - Cohen, S. B. AU - Baumgartner, S. W. AU - Tindall, E. A. AU - Bulpitt, K. AU - Martin, R. AU - Weinblatt, M. AU - Taborn, J. AU - Weaver, A. AU - Burge, D. J. AU - Schiff, M. H. PY - 2001 DA - 2001// TI - Longterm safety and efficacy of etanercept in patients with rheumatoid arthritis JO - J Rheumatol VL - 28 ID - Moreland2001 ER - TY - JOUR AU - Kavanaugh, A. AU - St Clair, E. W. AU - McCune, W. J. AU - Braakman, T. AU - Lipsky, P. PY - 2000 DA - 2000// TI - Chimeric anti-tumor necrosis factor-alfa monoclonal antibody treatment of patients with rheumatoid arthritis receibing methotrexate therapy JO - J Rheumatol VL - 27 ID - Kavanaugh2000 ER - TY - JOUR AU - Elliot, M. J. AU - Maini, R. N. AU - Feldmann, M. AU - Long-Fox, A. AU - Charles, P. AU - Bijl, H. AU - Woody, J. N. PY - 1994 DA - 1994// TI - Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patiens with rheumatoid arthritis JO - Lancet VL - 344 UR - https://doi.org/10.1016/S0140-6736(94)90632-7 DO - 10.1016/S0140-6736(94)90632-7 ID - Elliot1994 ER - TY - JOUR AU - O'Dell, J. R. AU - Petersen, K. AU - Leff, R. AU - Palmer, W. AU - Schned, E. AU - Blakely, K. AU - Haire, C. AU - Fernandez, A. PY - 2006 DA - 2006// TI - Etanercept in combination with sulfasalazine, hydroxychloroquine, or gold in the treatment of rheumatoid arthritis JO - J Rheumatol VL - 33 ID - O'Dell2006 ER - TY - JOUR AU - Finckh, A. AU - Simard, J. F. AU - Duryea, J. AU - Liang, M. H. AU - Huang, J. AU - Daneel, S. AU - Forster, A. AU - Gabay, C. AU - Guerne, P. A. PY - 2006 DA - 2006// TI - The effectiveness of anti-tumor necrosis factor therapy in preventing progressive radiographic joint damage in rheumatoid arthritis: a population-based study JO - Arthritis Rheum VL - 54 UR - https://doi.org/10.1002/art.21491 DO - 10.1002/art.21491 ID - Finckh2006 ER - TY - JOUR AU - Elliott, M. J. AU - Maini, R. N. AU - Feldmann, M. AU - Long-Fox, A. AU - Charles, P. AU - Katsikis, P. AU - Brennan, F. M. AU - Walker, J. AU - Bijl, H. AU - Ghrayeb, J. PY - 1993 DA - 1993// TI - Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha JO - Arthritis Rheum VL - 36 UR - https://doi.org/10.1002/art.1780361206 DO - 10.1002/art.1780361206 ID - Elliott1993 ER - TY - JOUR AU - Lan, J. L. AU - Chou, S. J. AU - Chen, D. Y. AU - Chen, Y. H. AU - Hsieh, T. Y. AU - Young, M. PY - 2004 DA - 2004// TI - A comparative study of etanercept plus methotrexate and methotrexate alone in Taiwanese patients with active rheumatoid arthritis: a 12-week, double-blind, randomized, placebo-controlled study JO - J Formos Med Assoc VL - 103 ID - Lan2004 ER - TY - JOUR AU - Durez, P. AU - Nzeusseu Toukap, A. AU - Lauwerys, B. R. AU - Manicourt, D. H. AU - Verschueren, P. AU - Westhovens, R. AU - Devogelaer, J. P. AU - Houssiau, F. A. PY - 2004 DA - 2004// TI - A randomised comparative study of the short term clinical and biological effects of intravenous pulse methylprednisolone and infliximab in patients with active rheumatoid arthritis despite methotrexate treatment JO - Ann Rheum Dis VL - 63 UR - https://doi.org/10.1136/ard.2003.012914 DO - 10.1136/ard.2003.012914 ID - Durez2004 ER - TY - JOUR AU - Keystone, E. C. AU - Schiff, M. H. AU - Kremer, J. M. AU - Kafka, S. AU - Lovy, M. AU - DeVries, T. AU - Burge, D. J. PY - 2004 DA - 2004// TI - Once-weekly administration of 50 mg etanercept in patients with active rheumatoid arthritis: results of a multicenter, randomized, double-blind, placebo-controlled trial JO - Arthritis Rheum VL - 50 UR - https://doi.org/10.1002/art.20019 DO - 10.1002/art.20019 ID - Keystone2004 ER - TY - JOUR AU - van de Putte, L. B. AU - Rau, R. AU - Breedveld, F. C. AU - Kalden, J. R. AU - Malaise, M. G. AU - van Riel, P. L. AU - Schattenkirchner, M. AU - Emery, P. AU - Burmester, G. R. AU - Zeidler, H. AU - Moutsopoulos, H. M. AU - Beck, K. AU - Kupper, H. PY - 2003 DA - 2003// TI - Efficacy and safety of the fully human anti-tumour necrosis factor alpha monoclonal antibody adalimumab (D2E7) in DMARD refractory patients with rheumatoid arthritis: a 12 week, phase II study JO - Ann Rheum Dis VL - 62 UR - https://doi.org/10.1136/ard.2003.009563 DO - 10.1136/ard.2003.009563 ID - van de Putte2003 ER - TY - JOUR AU - Moreland, L. W. AU - Baumgartner, S. W. AU - Schiff, M. H. AU - Tindal, E. A. AU - Fleischmann, R. M. AU - Weaver, A. L. PY - 1997 DA - 1997// TI - Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein JO - N Engl J Med VL - 337 UR - https://doi.org/10.1056/NEJM199707173370301 DO - 10.1056/NEJM199707173370301 ID - Moreland1997 ER - TY - JOUR AU - Elliot, M. J. AU - Maini, R. N. AU - Feldmann, M. AU - Kalden, J. R. AU - Antoni, C. AU - Smolen, J. S. AU - Breedveld, F. C. AU - Macfarlane, J. D. AU - Bijl, H. PY - 1994 DA - 1994// TI - Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alfa(cA2) versus placebo in rheumatoid arthritis JO - Lancet VL - 344 UR - https://doi.org/10.1016/S0140-6736(94)90628-9 DO - 10.1016/S0140-6736(94)90628-9 ID - Elliot1994 ER - TY - JOUR AU - Rau, R. AU - Simianer, S. AU - van Riel, P. L. AU - van de Putte, L. B. AU - Kruger, K. AU - Schattenkirchner, M. PY - 2004 DA - 2004// TI - Rapid alleviation of signs and symptoms of rheumatoid arthritis with intravenous or subcutaneous administration of adalimumab in combination with methotrexate JO - Scand J Rheumatol VL - 33 UR - https://doi.org/10.1080/03009740410005467 DO - 10.1080/03009740410005467 ID - Rau2004 ER - TY - JOUR AU - Weisman, M. H. AU - Moreland, L. W. AU - Furst, D. E. AU - Weinblatt, M. E. AU - Keystone, E. C. AU - Paulus, H. E. AU - Teoh, L. S. AU - Velagapudi, R. B. AU - Noertersheuser, P. A. AU - Granneman, G. R. AU - Fischkoff, S. A. AU - Chartash, E. K. PY - 2003 DA - 2003// TI - Efficacy, pharmacokinetic, and safety assessment of adalimumab, a fully human anti-tumor necrosis factor-alpha monoclonal antibody, in adults with rheumatoid arthritis receiving concomitant methotrexate: a pilot study JO - Clin Ther VL - 25 UR - https://doi.org/10.1016/S0149-2918(03)80164-9 DO - 10.1016/S0149-2918(03)80164-9 ID - Weisman2003 ER - TY - JOUR AU - Broeder, A. AU - van de Putte, L. B. A. AU - Rau, R. AU - Schattenkirchner, M. AU - van Riedel, L. C. M. AU - Sander, O. AU - Binder, C. AU - Fenner, H. AU - Bankmann, Y. AU - Velagapudi, R. AU - Kempeni, J. AU - Kupper, H. PY - 2002 DA - 2002// TI - A single dose, placebo controlled study of the fully human anti-tumor necrosis factor-alfa antibody adalimumab (D2E7) in patients with rheumatoid arthritis JO - J Rheumatol VL - 29 ID - Broeder2002 ER - TY - JOUR AU - Moreland, L. W. AU - Margolies, G. AU - Heck, L. W. AU - Saway, A. AU - Blosch, C. AU - Hanna, R. AU - Koopman, W. J. PY - 1996 DA - 1996// TI - Recombinant soluble tumor necrosis factor receptor (p80) fusion protein: toxicity and dose finding trial in refractory rheumatoid arthritis JO - J Rheumatol VL - 23 ID - Moreland1996 ER - TY - JOUR AU - Torrance, G. W. AU - Tugwell, P. AU - Amorosi, S. AU - Chartash, E. AU - Sengupta, N. PY - 2004 DA - 2004// TI - Improvement in health utility among patients with rheumatoid arthritis treated with adalimumab (a human anti-TNF monoclonal antibody) plus methotrexate JO - Rheumatology (Oxford) VL - 43 UR - https://doi.org/10.1093/rheumatology/keh153 DO - 10.1093/rheumatology/keh153 ID - Torrance2004 ER - TY - JOUR AU - Mathias, S. D. AU - Colwell, H. H. AU - Miller, D. P. AU - Moreland, L. W. AU - Buatti, M. AU - Wanke, L. PY - 2000 DA - 2000// TI - Health-related quality of life and functional status of patients with rheumatoid arthritis randomly assigned to receive etanercept or placebo JO - Clin Ther VL - 22 UR - https://doi.org/10.1016/S0149-2918(00)87984-9 DO - 10.1016/S0149-2918(00)87984-9 ID - Mathias2000 ER - TY - JOUR AU - van der Heijde, D. AU - Klareskog, L. AU - Singh, A. AU - Tornero, J. AU - Melo-Gomes, J. AU - Codreanu, C. AU - Pedersen, R. AU - Freundlich, B. AU - Fatenejad, S. PY - 2006 DA - 2006// TI - Patient reported outcomes in a trial of combination therapy with etanercept and methotrexate for rheumatoid arthritis: the TEMPO trial JO - Ann Rheum Dis VL - 65 UR - https://doi.org/10.1136/ard.2005.035709 DO - 10.1136/ard.2005.035709 ID - van der Heijde2006 ER - TY - JOUR AU - Breedveld, F. C. AU - Emery, P. AU - Keystone, E. AU - Patel, K. AU - Furst, D. E. AU - Kalden, J. R. AU - St Clair, E. W. AU - Weisman, M. AU - Smolen, J. AU - Lipsky, P. E. AU - Maini, R. N. PY - 2004 DA - 2004// TI - Infliximab in active early rheumatoid arthritis JO - Ann Rheum Dis VL - 63 UR - https://doi.org/10.1136/ard.2003.013961 DO - 10.1136/ard.2003.013961 ID - Breedveld2004 ER - TY - JOUR AU - Smolen, J. S. AU - Van Der Heijde, D. M. AU - St Clair, E. W. AU - Emery, P. AU - Bathon, J. M. AU - Keystone, E. AU - Maini, R. N. AU - Kalden, J. R. AU - Schiff, M. AU - Baker, D. AU - Han, C. AU - Han, J. AU - Bala, M. PY - 2006 DA - 2006// TI - Active-Controlled Study of Patients Receiving Infliximab for the Treatment of Rheumatoid Arthritis of Early Onset (ASPIRE) Study Group. Predictors of joint damage in patients with early rheumatoid arthritis treated with high-dose methotrexate with or without concomitant infliximab: results from the ASPIRE trial JO - Arthritis Rheum VL - 54 UR - https://doi.org/10.1002/art.21678 DO - 10.1002/art.21678 ID - Smolen2006 ER - TY - JOUR AU - Maini, R. N. AU - Breedveld, F. C. AU - Kalden, J. R. AU - Smolen, J. S. AU - Davis, D. AU - Macfarlane, J. C. AU - Antoni, C. AU - Leeb, B. AU - Elliott, M. J. AU - Woody, J. N. AU - Schaible, T. F. AU - Feldmann, M. PY - 1998 DA - 1998// TI - Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis JO - Arthritis Rheum VL - 41 UR - https://doi.org/3.0.CO;2-W DO - 3.0.CO;2-W ID - Maini1998 ER - TY - JOUR AU - Maini, R. N. AU - Breedveld, F. C. AU - Kalden, J. R. AU - Smolen, J. S. AU - Furst, D. AU - Weisman, M. H. PY - 2004 DA - 2004// TI - Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate JO - Arthritis Rheum VL - 50 UR - https://doi.org/10.1002/art.20159 DO - 10.1002/art.20159 ID - Maini2004 ER - TY - JOUR AU - St Clair, E. W. AU - Wagner, C. L. AU - Fasanmade, A. A. AU - Wang, B. AU - Schaible, T. AU - Kavanaugh, A. AU - Keystone, E. C. PY - 2002 DA - 2002// TI - The relationship of serum infliximab concentrations to clinical improvement in rheumatoid arthritis: results from ATTRACT, a multicenter, randomized, double-blind, placebo-controlled trial JO - Arthritis Rheum VL - 46 UR - https://doi.org/10.1002/art.10302 DO - 10.1002/art.10302 ID - St Clair2002 ER - TY - JOUR AU - van de Putte, L. B. AU - Sander, O. AU - Rau, R. PY - 1998 DA - 1998// TI - Therapy of refractory chronic polyarthritis with tumor necrosis factor alpha receptor fusion proteins (TNFR55-IgG1) results of double-blind placebo-controlled studies over 3 months JO - Z Rheumatol VL - 57 UR - https://doi.org/10.1007/s003930050116 DO - 10.1007/s003930050116 ID - van de Putte1998 ER - TY - JOUR AU - Taylor, P. C. AU - Steuer, A. AU - Gruber, J. AU - Cosgrove, D. O. AU - Blomley, M. J. AU - Marsters, P. A. AU - Wagner, C. L. AU - McClinton, C. AU - Maini, R. N. PY - 2004 DA - 2004// TI - Comparison of ultrasonographic assessment of synovitis and joint vascularity with radiographic evaluation in a randomized, placebo-controlled study of infliximab therapy in early rheumatoid arthritis JO - Arthritis Rheum VL - 50 UR - https://doi.org/10.1002/art.20123 DO - 10.1002/art.20123 ID - Taylor2004 ER - TY - JOUR AU - Wiland, P. AU - Glowska, A. AU - Chlebicki, A. AU - Szechinski, J. PY - 2002 DA - 2002// TI - Analysis of efficacy and safety of multiple intravenous infusion of anti-tumor necrosis factor-alpha monoclonal antibody (Remicade) combined with methotrexate compared with sodium aurothiomalate and intramuscular depot methylprednisolone in rheumatoid arthritis JO - Pol Arch Med Wewn VL - 108 ID - Wiland2002 ER - TY - JOUR AU - Abe, T. AU - Takeuchi, T. AU - Miyasaka, N. AU - Hashimoto, H. AU - Kondo, H. AU - Ichikawa, Y. AU - Nagaya, I. PY - 2006 DA - 2006// TI - A multicenter, double-blind, randomized, placebo controlled trial of infliximab combined with low dose methotrexate in Japanese patients with rheumatoid arthritis JO - J Rheumatol VL - 33 ID - Abe2006 ER - TY - JOUR AU - Van Gestel, A. M. AU - Haagesma, C. J. AU - Van riel, P. L. C. M. PY - 1998 DA - 1998// TI - Validación of rheumatoid arthritis improvement criteria including simplified joint counts JO - Arthritis Rheum VL - 41 UR - https://doi.org/3.0.CO;2-K DO - 3.0.CO;2-K ID - Van Gestel1998 ER - TY - JOUR AU - Bacon, P. AU - Reynols, A. V. PY - 2002 DA - 2002// TI - The efficacy of etanercept and infliximab in patients with rheumatoid arthritis who have failed treatment with DMARDs: a meta-analysis (abstract) JO - Arthritis Rheum VL - 46 ID - Bacon2002 ER - TY - JOUR AU - Sing, A. AU - Nab, H. PY - 2003 DA - 2003// TI - A meta-analysis of biological response modifiers in the treatment of rheumatoid arthritis for patients failing one or more disease modifying antirheumatic drugs (abstract THU0250) JO - Ann Rheum Dis VL - 62 ID - Sing2003 ER - TY - JOUR AU - Chen, Y. F. AU - Jobanputra, P. AU - Barton, P. AU - Jowett, S. AU - Bryan, S. AU - Clark, W. PY - 2006 DA - 2006// TI - A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness JO - Health Technol Assess VL - 10 UR - https://doi.org/10.3310/hta10420 DO - 10.3310/hta10420 ID - Chen2006 ER - TY - JOUR AU - Dixon, W. AU - Silman, A. PY - 2007 DA - 2007// TI - Is there an association between anti-TNF monoclonal antibody therapy in rheumatoid arthritis and risk of malignancy and serious infection? Commentary on meta-analysis by Bongartz et al JO - Arthritis Researh Therapy VL - 8 UR - https://doi.org/10.1186/ar2026 DO - 10.1186/ar2026 ID - Dixon2007 ER - TY - JOUR AU - Kristensen, L. E. AU - Christensen, R. AU - Bliddal, H. AU - Geborek, P. AU - Danneskiold-Samsee, B. AU - Saxne, T. PY - 2007 DA - 2007// TI - The number needed to treat for adalimumab, etanercept, and infliximab based on ACR50 response in three randomized controlled trials on established rheumatoid arthritis: a systematic literature review JO - Scand J Rheumatol VL - 36 UR - https://doi.org/10.1080/03009740701607067 DO - 10.1080/03009740701607067 ID - Kristensen2007 ER - TY - STD TI - Lee YH, Woo JH, Rho YH, Choi SJ, Ji JD, Song GG: Meta-analysis of the combination of TNF inhibitors plus MTX compared to MTX monotherapy, and the adjusted indirect comparison of TNF inhibitors in patients suffering from active rheumatoid arthritis. Rheumatol Int. ID - ref71 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2474/9/52/prepub UR - http://www.biomedcentral.com/1471-2474/9/52/prepub ID - ref72 ER -